FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lanoxin (digoxin) Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Concordia Pharmaceuticals Inc. (New 05/22/2018)

Company Contact Information:

Presentation Posting Date Related Information
Lanoxin (digoxin) 187.5 mcg (0.1875 mg) tablets; 100-count bottles (NDC 59212-245-55) 05/22/2018 A business decision was made to discontinue manufacture and supply of the Lanoxin 187.5 mcg (0.1875 mg) strength tablets. All existing lots on the market are good through expiry. The anticipated final date of availability for sale is June 30, 2018 (NDC 59212-245-55).

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English